NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
ID: 343934Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $450K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343934

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-062.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing health disparities related to HIV and substance use among underserved racial and ethnic populations. This initiative invites pilot or feasibility research that explores structural, organizational, and social factors contributing to these inequities, with a focus on promoting racial equity and developing innovative prevention and treatment strategies that consider intersectionality across various identities. Funding of up to $450,000 is available over three years for projects that demonstrate community engagement and address documented disparities in HIV and substance abuse outcomes. Interested applicants must submit their proposals by November 14, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DA-23-062-Full-Announcement.html
    RFA-DA-23-062.html
    The National Institute on Drug Abuse (NIDA) within the Department of Health and Human Services has issued a funding opportunity aimed at addressing health disparities related to HIV and substance use among underserved racial and ethnic populations. This initiative, titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," invites pilot or feasibility research on structural, organizational, and social factors contributing to these inequities. The aim is to promote racial equity within NIDA’s research efforts and to develop novel prevention and treatment strategies that consider intersectionality across various identities. Funding of up to $450,000 over three years is available for innovative projects demonstrating community engagement and addressing documented disparities in HIV and substance abuse outcomes. Applications must include a Plan for Enhancing Diverse Perspectives to promote inclusivity and collaboration with community organizations. The deadlines for submission, project eligibility, and other key details are outlined, ensuring the initiative aligns with broader public health goals to reduce HIV infections in the U.S. This RFA reinforces the NIH’s commitment to health equity research while targeting persistent disparities affecting marginalized groups.
    Similar Opportunities
    NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R34 Planning Grant under its Racial Equity Initiative (REI), aimed at addressing HIV-related health disparities among underserved racial and ethnic populations. This funding opportunity supports pilot or feasibility research that explores the social, structural, and contextual factors contributing to inequities at the intersection of HIV and substance use, while encouraging projects that consider individuals' multidimensional identities. The initiative is critical in promoting health equity and aligns with the HHS's goal of ending the HIV epidemic by 2030, with a total budget of $3 million available to fund 5 to 9 projects, each with direct cost requests up to $450,000 over three years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by November 14, 2024.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research," aimed at supporting R01 applications that focus on community-partnered research to mitigate disparities in substance misuse and health outcomes among racial and ethnic minority populations. This initiative emphasizes the establishment of collaborative community partnerships to ensure that research addresses immediate community needs and employs effective methodologies, thereby advancing health equity in the context of substance use and addiction. The program has a budget of approximately $2 million for FY 2023, with applications due by November 14, 2024. Interested applicants can find more information and application instructions at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions." This initiative invites R01 applications aimed at conducting impactful research to address disparities in substance use and addiction outcomes among racial and ethnic minority populations, emphasizing community engagement and collaboration with community organizations. The program is part of NIDA's broader Racial Equity Initiative, which seeks to improve health equity and reduce health disparities, with approximately $2 million anticipated for funding across multiple related announcements. Interested applicants, particularly from minority-serving institutions, must submit proposals by November 14, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)" aimed at supporting innovative research at the intersection of HIV and substance use. This initiative seeks proposals that address critical gaps in understanding and improving health outcomes for individuals living with HIV who also face substance use disorders, requiring detailed research plans and preliminary data from both individual researchers and research teams. NIH plans to allocate approximately $3 million annually for three to five awards over three years, with applications due by January 11, 2025, and a strong emphasis on enhancing diverse perspectives through an inclusion plan. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-024.html.
    NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity, aimed at supporting innovative research that addresses disparities in substance use among underserved racial and ethnic minority groups in the U.S. This initiative invites applications from early career or established scholars who propose high-impact projects that challenge existing paradigms and foster community engagement to tackle systemic factors impacting health disparities. With a funding commitment of approximately $2 million annually for 2-3 awards, applicants can request up to $700,000 in direct costs per year for a maximum project period of five years. Interested applicants should submit their proposals by November 14, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. For more details, visit the official announcement at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html.
    Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services," aimed at supporting innovative research in integrated care models for HIV/AIDS and substance use disorders. The initiative seeks to improve health outcomes and enhance care coordination for individuals at heightened risk by addressing service delivery gaps through collaborative and evidence-based practices. This grant, with a funding ceiling of $450,000 over three years, is open to a diverse range of eligible applicants, including higher education institutions and community-based organizations, with applications due by March 19, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-020.html.
    Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)." This initiative aims to encourage research into the role of inflammasomes in the neuropathology associated with HIV infection and substance use disorders, particularly focusing on their impact on neurocognitive disorders and immune function. The program seeks to bridge knowledge gaps in treatment and research by exploring how inflammasome activation is influenced by HIV and substance use, with the goal of translating findings into clinical applications. A total funding amount of $2 million is available to support up to four grants, with a submission deadline of February 13, 2024. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the Racial Equity Visionary Award Program to support innovative research addressing substance use disparities among underserved racial and ethnic minority groups. This funding opportunity invites early career and established scholars from domestic minority-serving institutions to submit proposals that challenge existing scientific paradigms and aim for transformative impacts in health equity. NIDA plans to allocate approximately $2 million annually for 2-3 awards, with each application budget capped at $700,000 for projects lasting up to five years. Interested applicants must adhere to NIH guidelines and submit their proposals by November 14, 2024, with further inquiries directed to OERWebmaster03@od.nih.gov.
    Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity (PA-21-205) aimed at the development and testing of innovative interventions to enhance HIV prevention, treatment, and program implementation for individuals who use drugs. This R34 grant focuses on formative research and pilot studies that assess the feasibility, safety, and acceptability of various interventions, including behavioral, social, and structural approaches, particularly integrating substance use considerations into HIV care. The initiative is crucial in addressing the ongoing challenges of the HIV epidemic among populations significantly impacted by substance use, with projects expected to enhance HIV testing, preventive services, and treatment adherence. Interested applicants can apply for grants with a ceiling of $225,000, and the application deadline is January 7, 2025. For further information, contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-205.html.